Cinaciguat
Cinaciguat (BAY 58-2667) is a pioneering soluble guanylate cyclase (sGC) activator developed for treating acute decompensated heart failure. It is widely used in cardiovascular research to study sGC function and hemodynamics in both in vitro assays and in vivo heart failure models.
Product Specifications
CAS Number
329773-35-5
Product Name Alternative
Inhibit, Inhibitor, Guanylatecyclase, guanylate cyclase, Guanylate Cyclase, Guanylate cyclase, Cinaciguat, BAY 58-2667
Field of Research
Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:45 mg/mL (79.55 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (3.54 mM)
Smiles
O (CC1=CC=C (CCC2=CC=CC=C2) C=C1) C3=C (CCN (CC4=CC=C (C (O) =O) C=C4) CCCCC (O) =O) C=CC=C3
Molecular Formula
C36H39NO5
Molecular Weight
565.7
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6239858-01 0.1 mL
PCDHGA1 (Protocadherin gamma Subfamily A, 1, MGC138287, MGC138289, PCDH-GAMMA-A1) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6239858-02 5x 0.1 mL
PCDHGA1 (Protocadherin gamma Subfamily A, 1, MGC138287, MGC138289, PCDH-GAMMA-A1) (MaxLight 750)
Sign In for Pricing
View Details 
